Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Vaccines

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 85 articles: HTML format Text format

Single Articles

May 2012
1. HSIEH YC , Chiu CH, Chang KY, Huang YC, et al
   The Impact of the Heptavalent Pneumococcal Conjugate Vaccine on Risk Factors for Streptococcus pneumoniae Carriage in Children.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HEMMING M , Vesikari T
   Vaccine Derived Human-Bovine Double Reassortant Rotavirus in Infants with Acute Gastroenteritis.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KLUTHE M , Herrera A, Blanca H, Leung J, et al
   Neonatal Vaccine-Strain Varicella Zoster Virus Infection 22 Days after Maternal Post-Partum Vaccination.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
4. BLATTER MM , Klein NP, Shepard JS, Leonardi M, et al
   Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Co-Administered with Hepatitis A and Pneumococcal Conjugate Vaccines to Children 12 14 Months of Age.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MACIAS M , Lanata CF, Zambrano B, Gil AI, et al
   Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent: DTaP IPV Hep B PRP T Vaccine at 2, 4, 6 Months of Age Compared to Licensed Vaccines in Latin America.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. BLOCK SL , Ruiz-Palacios GM, Guerrero ML, Beygo J, et al
   A Dose-Range Study of MF59(R)-Adjuvanted Versus Non-Adjuvanted Monovalent A/H1N1 Pandemic Influenza Vaccine in 6 to <36 Month-Old Children.
   Pediatr Infect Dis J. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. METZ JA , Hanieh S, Pradhan R, Joshi A, et al
   Evaluation of Haemophilus influenzae Type b Vaccine for Routine Immunization in Nepali Infants.
   Pediatr Infect Dis J. 2012;31:e66-72.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NASSIM C , Christensen S, Henry D, Holmes S, et al
   Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to 1 Year After Immunization With a Pandemic A/H1N1 Influenza Vaccine in Children 3 to ,9 Years of Age.
   Pediatr Infect Dis J. 2012;31:e59-65.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. VERGISON A , Hanquet G
   Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.
   Pediatr Infect Dis J. 2012;31:400-3.
   PubMed     Text format     Related articles   
   
   
   
   March 2012
10. LAMBE T , Spencer AJ, Mullarkey CE, Antrobus RD, et al
    T-Cell Responses in Children to Internal Influenza Antigens, 1 Year after Immunization with Pandemic H1N1 Influenza Vaccine, and Response to Revaccination with Seasonal Trivalent Inactivated Influenza Vaccine.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. BLOCK SL , Falloon J, Hirschfield JA, Krilov LR, et al
    The Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. HECHTER RC , Chao C, Li Q, Jacobsen SJ, et al
    Correlates for Second-Dose Varicella Vaccination in School-Age Children in a Managed Care Organization in California.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. SHANN F
    Commentary: BCG Vaccination Halves Neonatal Mortality.
    Pediatr Infect Dis J. 2012;31:308-9.
    PubMed     Text format     Related articles   
    
    
    
    
14. COHEN R , Levy C, Bingen E, Koskas M, et al
    Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media.
    Pediatr Infect Dis J. 2012;31:297-301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. AMPOFO K , Pavia AT, Chris S, Hersh AL, et al
    The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era: A Case for Continuous Surveillance.
    Pediatr Infect Dis J. 2012;31:228-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
16. MALTEZOU HC , Lourida A, Katragkou A, Katerelos P, et al
    Attitudes Regarding Occupational Vaccines and Vaccination Coverage against Vaccine-Preventable Diseases among Health-Care Workers Working in Pediatric Departments in Greece.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. FINDLOW H , Borrow R, Andrews N, Waight P, et al
    Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. DOMACHOWSKE JB , Blatter M, Chandrasekaran V, Liu A, et al
    A Randomized, Controlled Trial in Children to Assess the Immunogenicity and Safety of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. FITZWATER SP , Chandran A, Santosham M, Johnson HL, et al
    The Worldwide Impact of the Seven-Valent Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GARGANO LM , Thacker N, Choudhury P, Weiss PS, et al
    Attitudes of Pediatricians and Primary Health Center Physicians in India Concerning Routine Immunization, Barriers to Vaccination, and Missed Opportunities to Vaccinate.
    Pediatr Infect Dis J. 2012;31:e37-e42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GRANT LR , Watt JP, Weatherholtz RC, Moulton LH, et al
    Efficacy of a Pentavalent Human-bovine Reassortant Rotavirus Vaccine Against Rotavirus Gastroenteritis Among American Indian Children.
    Pediatr Infect Dis J. 2012;31:184-188.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. JAFARI HS
    Commentary: Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children.
    Pediatr Infect Dis J. 2012;31:181-3.
    PubMed     Text format     Related articles   
    
    
    
    
23. VESIKARI T , Block SL, Guerra F, Lattanzi M, et al
    Immunogenicity, Safety, and Reactogenicity of a Mammalian Cell-Culture-Derived Influenza Vaccine in Healthy Children and Adolescents 3 to 17 Years of Age.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MARTINON-TORRES F , Gimenez-Sanchez F, Gurtman A, Bernaola E, et al
    13-valent Pneumococcal Conjugate Vaccine Given with Meningococcal C Tetanus Toxoid Conjugate and Other Routine Pediatric Vaccinations: Immunogenicity and Safety.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. NASSIM C , Christensen S, Henry D, Holmes S, et al
    Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
26. VESIKARI T , Prymula R, Schuster V, Tejedor JC, et al
    Efficacy and Immunogenicity of Live-Attenuated Human Rotavirus Vaccine in Breast-Fed and Formula-Fed European Infants.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ELLISON AM , Ota KV, McGowan KL, Smith-Whitley K, et al
    Pneumococcal Bacteremia in a Vaccinated Pediatric Sickle Cell Disease Population.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. OMENACA F , Sarlangue J, Szenborn L, Nogueira M, et al
    Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb Study.
    Pediatr Infect Dis J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HEININGER U
    Pertussis: what the pediatric infectious disease specialist should know.
    Pediatr Infect Dis J. 2012;31:78-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
30. BIERING-SORENSEN S , Aaby P, Napirna BM, Roth A, et al
    Small Randomized Trial among Low-Birth-Weight Children of Bacillus Calmette-Guerin Vaccination at First Health Center Contact.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LOUGHLIN J , Mast C, Doherty M, Wang FT, et al
    Post Marketing Evaluation of the Short-term Safety of the Pentavalent Rotavirus Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. LANGLEY JM , Halperin SA, Rubin E, White C, et al
    Safety and Immunogenicity of Two Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Cont
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. WROE PC , Lee GM, Finkelstein JA, Pelton SI, et al
    Pneumococcal Carriage and Antibiotic Resistance in Young Children before 13-Valent Conjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. DE SEVILLA MF , Garci JJ, Esteva C, Moraga F, et al
    Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. TREGNAGHI M , Zambrano B, Santos-Lima E
    Antibody Persistence Following a Primary Series of a New DTaP-IPV-Hep B-PRP-T Combined Vaccine or Separate DTaP-IPV//PRP approximately T and Hepatitis B Vaccines at 2, 4, and 6 Months of Age and the Effect of a Subsequent DTaP-IPV//PRP approximately T
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. GNANASHANMUGAM D , Troy SB, Musingwini G, Huang C, et al
    Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
37. LUABEYA KK , Mulenga H, Moyo S, Tameris M, et al
    Diagnostic Features Associated With Culture of Mycobacterium tuberculosis Among Young Children in a Vaccine Trial Setting.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MCVERNON J , Nolan T, Richmond P, Reynolds G, et al
    A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KLEIN NP , Reisinger KS, Johnston W, Odrljin T, et al
    Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-Conjugate Vaccine Given Concomitantly With Routine Vaccinations in Infants.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. WOOD N , Sheppeard V, Cashman P, Palasanthiran P, et al
    Influenza Vaccine Safety in Children Less Than 5 Years Old. The 2010 and 2011 Experience in Australia.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
41. AMPOFO K , Pavia AT, Stockmann CR, Blaschke AJ, et al
    Evolution of the Epidemiology of Pneumococcal Disease Among Utah Children Through the Vaccine Era.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SIBERRY GK , Warshaw MG, Williams PL, Spector SA, et al
    Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2- to 10-year-old Human Immunodeficiency Virus-infected Children.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. FRENCK R JR , Thompson A, Yeh SH, London A, et al
    Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BLACK S , Nicolay U, Vesikari T, Knuf M, et al
    Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. COULOIGNER V , Levy C, Francois M, Bidet P, et al
    Pathogens Implicated in Acute Otitis Media Failures After 7-valent Pneumococcal Conjugate Vaccine Implementation in France: Distribution, Serotypes, and Resistance Levels.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BLACK S
    Effectiveness of the pneumococcal conjugate vaccine for pneumonia in children.
    Pediatr Infect Dis J. 2011;30:917-8.
    PubMed     Text format     Related articles   
    
    
    
    
47. SKOWRONSKI DM , Hottes TS, De Serres G, Ward BJ, et al
    Influenza Beta/Victoria antigen induces strong recall of Beta/Yamagata but lower Beta/Victoria response in children primed with two doses of Beta/Yamagata.
    Pediatr Infect Dis J. 2011;30:833-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
48. VANDERKOOI OG , Scheifele DW, Girgenti D, Halperin SA, et al
    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. O'LEARY ST , Nelson C, Duran J
    Maternal Characteristics and Hospital Policies as Risk Factors for Nonreceipt of Hepatitis B Vaccine in the Newborn Nursery.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. BERNSTEIN DI , Malkin E, Abughali N, Falloon J, et al
    Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KNUF M , Pankow-Culot H, Grunert D, Rapp M, et al
    Induction of Immunologic Memory Following Primary Vaccination With the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Infants.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. KUSTERS MA , Jol-Van Der Zijde EC, Gijsbers RH, de Vries E, et al
    Decreased response after conjugated meningococcal serogroup C vaccination in children with down syndrome.
    Pediatr Infect Dis J. 2011;30:818-9.
    PubMed     Text format     Related articles   
    
    
    
    
53. BEHARRY MS , Coles MS, Burstein GR
    Adolescent immunization update.
    Pediatr Infect Dis J. 2011;30:787-90.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
54. KARRON RA , Casey R, Thumar B, Surman S, et al
    The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young Children.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KIM CH , Kim JS, Cha SH, Kim KN, et al
    Response to Primary and Booster Vaccination With 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. UHLIG U , Kostev K, Schuster V, Uhlig HH, et al
    Rotavirus Vaccination in Germany: Analysis of Nationwide Surveillance Data 2006 to 2010.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. WHEELER CM , Harvey BM, Pichichero ME, Simon MW, et al
    Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Ag
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. CUSTODIO H , Mirza A, Salahuddin A, Ferguson K, et al
    Cost-effectiveness of Hepatitis B Serology Testing Before Hepatitis B Vaccination in the Akha Tribal Children in Northeastern Thailand.
    Pediatr Infect Dis J. 2011;30:727.
    PubMed     Text format     Related articles   
    
    
    
    
59. BALE C , Garly ML, Martins C, Nielsen J, et al
    Risk factors for measles in young infants in an urban african area with high measles vaccination coverage.
    Pediatr Infect Dis J. 2011;30:689-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
60. THEODORIDOU K , Papaevangelou V, Papadogeorgaki E, Quinlivan M, et al
    Actinic Varicella Vaccine Rash.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MAST TC , Khawaja S, Espinoza F, Paniagua M, et al
    Case-control Study of the Effectiveness of Vaccination With Pentavalent Rotavirus Vaccine in Nicaragua.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. OMENACA F , Aristegui J, Tejedor JC, Moreno-Perez D, et al
    Combined Haemophilus Influenzae Type B-Neisseria Meningitidis Serogroup C Vaccine Is Immunogenic and Well Tolerated in Preterm Infants When Coadministered With Other Routinely Recommended Vaccines.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. FU C , Xu J, Tan H, Wang M, et al
    Serious Adverse Reactions Should be Further Monitored After Influenza A (H1N1) Vaccination Among Children: Postmarketing Experience With 570,000 Vaccinations Between October 2009 and August 2010 in Guangzhou, China.
    Pediatr Infect Dis J. 2011;30:631-2.
    PubMed     Text format     Related articles   
    
    
    
    
64. TOP KA , Esquilin JM, Yen C, Esona MD, et al
    Detection of Mutations in Antigenic Regions of Rotavirus Viral Proteins 4 and 7 in a Child With Chronic Shedding of Rotavirus Vaccine-type Strain.
    Pediatr Infect Dis J. 2011;30:630.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
65. ESPOSITO DH , Holman RC, Haberling DL, Tate JE, et al
    Baseline Estimates of Diarrhea-associated Mortality Among United States Children Before Rotavirus Vaccine Introduction.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. DE WHALLEY PC , Snape MD, Kelly DF, Banner C, et al
    Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
67. RINDERKNECHT S , Michaels MG, Blatter M, Gaglani M, et al
    Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Measles-mumps-rubella and Varicella Vaccines in Children Less Than 2 Years of Age.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SILFVERDAL SA , Skerlikova H, Zanova M, Papuchova D, et al
    Anamnestic Immune Response in 3- to 4-year-old Children Previously Immunized With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as 2 Dose or 3 Dose Priming and a Booster Dose in the First Year of Life.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. VESIKARI T , Martin JC, Liss CL, Liska V, et al
    Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. VESIKARI T , Karvonen A, Korhonen T, Karppa T, et al
    Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
71. MENDEZ-ECHEVARRIA A , Gonzalez-Munoz M, Mellado MJ, Baquero-Artigao F, et al
    Optimizing interpretation of the tuberculin test using an interferon-gamma release assay as a reference standard.
    Pediatr Infect Dis J. 2011;30:426-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
72. TROFA AF , Klein NP, Paul IM, Michaels MG, et al
    Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Diphtheria-tetanus-acellular Pertussis and Haemophilus influenzae Type B Vaccines in Children 15 Months of Age.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. VAN DEN BERGH MR , Spijkerman J, Francois N, Swinnen K, et al
    Immunogenicity, Safety, and Reactogenicity of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-Dose Primary Vaccination Schedule in the Netherlands: A Randomized Cont
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. JACOBS S , Warman A, Richardson R, Yacoub W, et al
    The Tuberculin Skin Test Is Unreliable in School Children BCG-vaccinated in Infancy and at Low Risk of Tuberculosis Infection.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. HANAGE WP , Bishop CJ, Huang SS, Stevenson AE, et al
    Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching.
    Pediatr Infect Dis J. 2011;30:302-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
76. RAES M , Strens D, Vergison A, Verghote M, et al
    Reduction in Pediatric Rotavirus-related Hospitalizations After Universal Rotavirus Vaccination in Belgium.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. PIREZ MC , Algorta G, Cedres A, Sobrero H, et al
    Impact of Universal Pneumococcal Vaccination on Hospitalizations for Pneumonia and Meningitis in Children in Montevideo, Uruguay.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ERNST E
    Anthroposophy: a risk factor for noncompliance with measles immunization.
    Pediatr Infect Dis J. 2011;30:187-9.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
79. 
    The pediatric infectious disease journal(R) newsletter: february 2011.
    Pediatr Infect Dis J. 2011;30:A9.
    PubMed     Text format     Related articles   
    
    
    
    
80. LIN MT , Wang JK, Yeh JI, Sun LC, et al
    Clinical Implication of the C Allele of the ITPKC Gene SNP rs28493229 in Kawasaki Disease: Association With Disease Susceptibility and BCG Scar Reactivation.
    Pediatr Infect Dis J. 2011;30:148-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. KOCH J , Wiese-Posselt M
    Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001-2008.
    Pediatr Infect Dis J. 2011;30:112-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
82. CURNS AT , Panozzo CA, Tate JE, Payne DC, et al
    Remarkable postvaccination spatiotemporal changes in United States rotavirus activity.
    Pediatr Infect Dis J. 2011;30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. DAGAN R , Bhutta ZA, de Quadros CA, Garau J, et al
    The remaining challenge of pneumonia: the leading killer of children.
    Pediatr Infect Dis J. 2011;30:1-2.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
84. KOLTE L , Rosenfeldt V, Vang L, Jeppesen D, et al
    Reduced Thymic Size but No Evidence of Impaired Thymic Function in Uninfected Children Born to Human Immunodeficiency Virus-infected Mothers.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
85. BECKER-DREPS S , Paniagua M, Dominik R, Cao H, et al
    Changes in Childhood Diarrhea Incidence in Nicaragua Following 3 Years of Universal Infant Rotavirus Immunization.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: